Cargando…

Effectiveness of a community program for older adults with type 2 diabetes and multimorbidity: a pragmatic randomized controlled trial

BACKGROUND: Type II diabetes mellitus (T2DM) affects upwards of 25% of Canadian older adults and is associated with high comorbidity and burden. Studies show that lifestyle factors and self-management are associated with improved health outcomes, but many studies lack rigour or exclude older adults,...

Descripción completa

Detalles Bibliográficos
Autores principales: Miklavcic, John J., Fraser, Kimberly D., Ploeg, Jenny, Markle-Reid, Maureen, Fisher, Kathryn, Gafni, Amiram, Griffith, Lauren E., Hirst, Sandra, Sadowski, Cheryl A., Thabane, Lehana, Triscott, Jean A. C., Upshur, Ross
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7218835/
https://www.ncbi.nlm.nih.gov/pubmed/32404059
http://dx.doi.org/10.1186/s12877-020-01557-0
_version_ 1783532871991951360
author Miklavcic, John J.
Fraser, Kimberly D.
Ploeg, Jenny
Markle-Reid, Maureen
Fisher, Kathryn
Gafni, Amiram
Griffith, Lauren E.
Hirst, Sandra
Sadowski, Cheryl A.
Thabane, Lehana
Triscott, Jean A. C.
Upshur, Ross
author_facet Miklavcic, John J.
Fraser, Kimberly D.
Ploeg, Jenny
Markle-Reid, Maureen
Fisher, Kathryn
Gafni, Amiram
Griffith, Lauren E.
Hirst, Sandra
Sadowski, Cheryl A.
Thabane, Lehana
Triscott, Jean A. C.
Upshur, Ross
author_sort Miklavcic, John J.
collection PubMed
description BACKGROUND: Type II diabetes mellitus (T2DM) affects upwards of 25% of Canadian older adults and is associated with high comorbidity and burden. Studies show that lifestyle factors and self-management are associated with improved health outcomes, but many studies lack rigour or exclude older adults, particularly those with multimorbidity. More evidence is needed on the effectiveness of community-based self-management programs in older adults with T2DM and multimorbidity. The study purpose is to evaluate the effect of a community-based intervention versus usual care on physical functioning, mental health, depressive symptoms, anxiety, self-efficacy, self-management, and healthcare costs in older adults with T2DM and 2 or more comorbidities. METHODS: Community-living older adults with T2DM and two or more chronic conditions were recruited from three Primary Care Networks (PCNs) in Alberta, Canada. Participants were randomly allocated to the intervention or control group in this pragmatic randomized controlled trial comparing the intervention to usual care. The intervention involved up to three in-home visits, a monthly group wellness program, monthly case conferencing, and care coordination. The primary outcome was physical functioning. Secondary outcomes included mental functioning, anxiety, depressive symptoms, self-efficacy, self-management, and the cost of healthcare service use. Intention-to-treat analysis was performed using ANCOVA modeling. RESULTS: Of 132 enrolled participants (70-Intervention, 62-Control), 42% were 75 years or older, 55% were female, and over 75% had at least six chronic conditions (in addition to T2DM). No significant group differences were seen for the baseline to six-month change in physical functioning (mean difference: -0.74; 95% CI: − 3.22, 1.74; p-value: 0.56), mental functioning (mean difference: 1.24; 95% CI: − 1.12, 3.60; p-value: 0.30), or other secondary outcomes.. CONCLUSION: No significant group differences were seen for the primary outcome, physical functioning (PCS). Program implementation, baseline differences between study arms and chronic disease management services that are part of usual care may have contributed to the modest study results. Fruitful areas for future research include capturing clinical outcome measures and exploring the impact of varying the type and intensity of key intervention components such as exercise and diet. TRIAL REGISTRATION: NCT02158741 Date of registration: June 9, 2014.
format Online
Article
Text
id pubmed-7218835
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-72188352020-05-20 Effectiveness of a community program for older adults with type 2 diabetes and multimorbidity: a pragmatic randomized controlled trial Miklavcic, John J. Fraser, Kimberly D. Ploeg, Jenny Markle-Reid, Maureen Fisher, Kathryn Gafni, Amiram Griffith, Lauren E. Hirst, Sandra Sadowski, Cheryl A. Thabane, Lehana Triscott, Jean A. C. Upshur, Ross BMC Geriatr Research Article BACKGROUND: Type II diabetes mellitus (T2DM) affects upwards of 25% of Canadian older adults and is associated with high comorbidity and burden. Studies show that lifestyle factors and self-management are associated with improved health outcomes, but many studies lack rigour or exclude older adults, particularly those with multimorbidity. More evidence is needed on the effectiveness of community-based self-management programs in older adults with T2DM and multimorbidity. The study purpose is to evaluate the effect of a community-based intervention versus usual care on physical functioning, mental health, depressive symptoms, anxiety, self-efficacy, self-management, and healthcare costs in older adults with T2DM and 2 or more comorbidities. METHODS: Community-living older adults with T2DM and two or more chronic conditions were recruited from three Primary Care Networks (PCNs) in Alberta, Canada. Participants were randomly allocated to the intervention or control group in this pragmatic randomized controlled trial comparing the intervention to usual care. The intervention involved up to three in-home visits, a monthly group wellness program, monthly case conferencing, and care coordination. The primary outcome was physical functioning. Secondary outcomes included mental functioning, anxiety, depressive symptoms, self-efficacy, self-management, and the cost of healthcare service use. Intention-to-treat analysis was performed using ANCOVA modeling. RESULTS: Of 132 enrolled participants (70-Intervention, 62-Control), 42% were 75 years or older, 55% were female, and over 75% had at least six chronic conditions (in addition to T2DM). No significant group differences were seen for the baseline to six-month change in physical functioning (mean difference: -0.74; 95% CI: − 3.22, 1.74; p-value: 0.56), mental functioning (mean difference: 1.24; 95% CI: − 1.12, 3.60; p-value: 0.30), or other secondary outcomes.. CONCLUSION: No significant group differences were seen for the primary outcome, physical functioning (PCS). Program implementation, baseline differences between study arms and chronic disease management services that are part of usual care may have contributed to the modest study results. Fruitful areas for future research include capturing clinical outcome measures and exploring the impact of varying the type and intensity of key intervention components such as exercise and diet. TRIAL REGISTRATION: NCT02158741 Date of registration: June 9, 2014. BioMed Central 2020-05-13 /pmc/articles/PMC7218835/ /pubmed/32404059 http://dx.doi.org/10.1186/s12877-020-01557-0 Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research Article
Miklavcic, John J.
Fraser, Kimberly D.
Ploeg, Jenny
Markle-Reid, Maureen
Fisher, Kathryn
Gafni, Amiram
Griffith, Lauren E.
Hirst, Sandra
Sadowski, Cheryl A.
Thabane, Lehana
Triscott, Jean A. C.
Upshur, Ross
Effectiveness of a community program for older adults with type 2 diabetes and multimorbidity: a pragmatic randomized controlled trial
title Effectiveness of a community program for older adults with type 2 diabetes and multimorbidity: a pragmatic randomized controlled trial
title_full Effectiveness of a community program for older adults with type 2 diabetes and multimorbidity: a pragmatic randomized controlled trial
title_fullStr Effectiveness of a community program for older adults with type 2 diabetes and multimorbidity: a pragmatic randomized controlled trial
title_full_unstemmed Effectiveness of a community program for older adults with type 2 diabetes and multimorbidity: a pragmatic randomized controlled trial
title_short Effectiveness of a community program for older adults with type 2 diabetes and multimorbidity: a pragmatic randomized controlled trial
title_sort effectiveness of a community program for older adults with type 2 diabetes and multimorbidity: a pragmatic randomized controlled trial
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7218835/
https://www.ncbi.nlm.nih.gov/pubmed/32404059
http://dx.doi.org/10.1186/s12877-020-01557-0
work_keys_str_mv AT miklavcicjohnj effectivenessofacommunityprogramforolderadultswithtype2diabetesandmultimorbidityapragmaticrandomizedcontrolledtrial
AT fraserkimberlyd effectivenessofacommunityprogramforolderadultswithtype2diabetesandmultimorbidityapragmaticrandomizedcontrolledtrial
AT ploegjenny effectivenessofacommunityprogramforolderadultswithtype2diabetesandmultimorbidityapragmaticrandomizedcontrolledtrial
AT marklereidmaureen effectivenessofacommunityprogramforolderadultswithtype2diabetesandmultimorbidityapragmaticrandomizedcontrolledtrial
AT fisherkathryn effectivenessofacommunityprogramforolderadultswithtype2diabetesandmultimorbidityapragmaticrandomizedcontrolledtrial
AT gafniamiram effectivenessofacommunityprogramforolderadultswithtype2diabetesandmultimorbidityapragmaticrandomizedcontrolledtrial
AT griffithlaurene effectivenessofacommunityprogramforolderadultswithtype2diabetesandmultimorbidityapragmaticrandomizedcontrolledtrial
AT hirstsandra effectivenessofacommunityprogramforolderadultswithtype2diabetesandmultimorbidityapragmaticrandomizedcontrolledtrial
AT sadowskicheryla effectivenessofacommunityprogramforolderadultswithtype2diabetesandmultimorbidityapragmaticrandomizedcontrolledtrial
AT thabanelehana effectivenessofacommunityprogramforolderadultswithtype2diabetesandmultimorbidityapragmaticrandomizedcontrolledtrial
AT triscottjeanac effectivenessofacommunityprogramforolderadultswithtype2diabetesandmultimorbidityapragmaticrandomizedcontrolledtrial
AT upshurross effectivenessofacommunityprogramforolderadultswithtype2diabetesandmultimorbidityapragmaticrandomizedcontrolledtrial